{
  "type": "hyp",
  "text": "Inhibition of NF-kappaB has been achieved by pharmacological and genetic approaches; however monocyte interactions with activated endothelium in shear flow following gene transfer of the NF-kappaB inhibitor IkappaB-alpha have not been studied.\n",
  "self": {
    "NER": {
      "answers": [
        "NF"
      ],
      "QG_hash=ThomasNLG/t5-qg_squad1-en": {
        "questions": [
          "What is the name of the molecule that is inhibited by IkappaB"
        ]
      }
    },
    "NOUN": {
      "answers": [
        "Inhibition",
        "NF-kappaB",
        "pharmacological and genetic approaches",
        "interactions",
        "activated endothelium",
        "shear flow",
        "gene transfer",
        "the NF-kappaB inhibitor",
        "IkappaB-alpha"
      ],
      "QG_hash=ThomasNLG/t5-qg_squad1-en": {
        "questions": [
          "What is the goal of pharmacological and genetic approaches?",
          "What is inhibited by pharmacological and genetic approaches?",
          "What methods have been used to inhibit NF-kappaB?",
          "What has not been studied in the study of monocytes?",
          "What do monocytes interact with in shear flow?",
          "What is the process that causes monocyte interactions with activated endothelium?",
          "What is the cause of monocyte interactions with activated endothelium?",
          "What is IkappaB-alpha?",
          "What is the name of the NF-kappaB inhibitor that has not been studied"
        ]
      }
    }
  },
  "asked": {
    "What might be relevant for designing future therapeutic strategies?": {
      "QA_hash=ThomasNLG/t5-qa_squad2neg-en": {
        "answer": "unanswerable",
        "answerability": 0.013215363025665283,
        "ground_truth": {
          "Findings": {
            "bertscore": 0.7192396521568298,
            "f1": 0
          }
        }
      }
    },
    "What promotes leukocyte-endothelium interaction?": {
      "QA_hash=ThomasNLG/t5-qa_squad2neg-en": {
        "answer": "unanswerable",
        "answerability": 0.0016900300979614258,
        "ground_truth": {
          "xenogeneic serum": {
            "bertscore": 0.6681813597679138,
            "f1": 0
          }
        }
      }
    },
    "What does xenogeneic serum promote?": {
      "QA_hash=ThomasNLG/t5-qa_squad2neg-en": {
        "answer": "unanswerable",
        "answerability": 0.0001653432846069336,
        "ground_truth": {
          "leukocyte-endothelium interaction": {
            "bertscore": 0.5988408327102661,
            "f1": 0
          }
        }
      }
    },
    "What is the possible mechanism of leukocyte-endothelium interaction?": {
      "QA_hash=ThomasNLG/t5-qa_squad2neg-en": {
        "answer": "unanswerable",
        "answerability": 0.0027756690979003906,
        "ground_truth": {
          "NF-kappa B activation": {
            "bertscore": 0.6154857873916626,
            "f1": 0
          }
        }
      }
    },
    "What could the findings of xenogeneic serum be relevant for designing?": {
      "QA_hash=ThomasNLG/t5-qa_squad2neg-en": {
        "answer": "unanswerable",
        "answerability": 0.0005404353141784668,
        "ground_truth": {
          "future therapeutic strategies": {
            "bertscore": 0.6367928981781006,
            "f1": 0
          }
        }
      }
    },
    "What is the purpose of a xenogeneic serum study?": {
      "QA_hash=ThomasNLG/t5-qa_squad2neg-en": {
        "answer": "unanswerable",
        "answerability": 0.0013990998268127441,
        "ground_truth": {
          "xenograft survival": {
            "bertscore": 0.6740760207176208,
            "f1": 0
          }
        }
      }
    }
  }
}